BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9355036)

  • 21. Sexually dimorphic effects of maternal adrenalectomy on hypothalamic corticotrophin-releasing factor, glucocorticoid receptor and anterior pituitary POMC mRNA levels in rat neonates.
    Halasz I; Rittenhouse PA; Zorrilla EP; Redei E
    Brain Res Dev Brain Res; 1997 Jun; 100(2):198-204. PubMed ID: 9205810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids.
    Ma XM; Aguilera G
    Endocrinology; 1999 Dec; 140(12):5642-50. PubMed ID: 10579328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotargeted lesions of paraventricular CRF and AVP neurons in developing rats reveal the pattern of maturation of these systems and their functional importance.
    Walker CD; Tankosic P; Tilders FJ; Burlet A
    J Neuroendocrinol; 1997 Jan; 9(1):25-41. PubMed ID: 9023736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat.
    Luo X; Kiss A; Makara G; Lolait SJ; Aguilera G
    J Neuroendocrinol; 1994 Dec; 6(6):689-96. PubMed ID: 7894472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
    Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
    Butterweck V; Winterhoff H; Herkenham M
    Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of hypothalamic corticotropin-releasing factor and anterior pituitary pro-opiomelanocortin expression in male and female offspring of alcohol-exposed and adrenalectomized dams.
    Aird F; Halasz I; Redei E
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1560-6. PubMed ID: 9438513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of corticotropin-releasing hormone messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus and proopiomelanocortin mRNA in the anterior pituitary during late gestation in fetal sheep.
    Myers DA; Myers TR; Grober MS; Nathanielsz PW
    Endocrinology; 1993 May; 132(5):2109-16. PubMed ID: 8386607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of proopiomelanocortin gene transcription during single and repeated immobilization stress.
    Noguchi T; Makino S; Maruyama H; Hashimoto K
    Neuroendocrinology; 2006; 84(1):21-30. PubMed ID: 17085933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain.
    Givalois L; Li S; Pelletier G
    Neuroendocrinology; 1998 Aug; 68(2):98-104. PubMed ID: 9705576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential and temporal expression of corticotropin releasing hormone and its receptors in the nucleus of the hippocampal commissure and paraventricular nucleus during the stress response in chickens (Gallus gallus).
    Kadhim HJ; Kang SW; Kuenzel WJ
    Brain Res; 2019 Jul; 1714():1-7. PubMed ID: 30772274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticotropin-releasing factor receptor expression in the pituitary of fetal sheep after lesion of the hypothalamic paraventricular nucleus.
    Myers DA; Bell ME; McDonald TJ; Myers TR
    Endocrinology; 1999 Sep; 140(9):4292-9. PubMed ID: 10465303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress.
    Shepard JD; Liu Y; Sassone-Corsi P; Aguilera G
    J Neurosci; 2005 Apr; 25(16):4073-81. PubMed ID: 15843609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of corticotropin-releasing hormone (CRH) transcription and CRH mRNA stability by glucocorticoids.
    Ma XM; Camacho C; Aguilera G
    Cell Mol Neurobiol; 2001 Oct; 21(5):465-75. PubMed ID: 11860185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
    Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
    Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency.
    Muglia LJ; Jacobson L; Luedke C; Vogt SK; Schaefer ML; Dikkes P; Fukuda S; Sakai Y; Suda T; Majzoub JA
    J Clin Invest; 2000 May; 105(9):1269-77. PubMed ID: 10792002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of pituitary corticotropin releasing hormone receptors.
    Aguilera G; Rabadan-Diehl C; Nikodemova M
    Peptides; 2001 May; 22(5):769-74. PubMed ID: 11337090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic corticotropin-releasing hormone expression in the baboon fetus at mid- and late gestation.
    Davies WA; Albrecht ED; Pepe GJ
    Biol Reprod; 1996 Sep; 55(3):559-66. PubMed ID: 8862772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.